Clinical Trial Update: An Open Label Study of Severe Sepsis in Adults [Phase 4]

View source ↗

Summary

An open-label Phase 4 study of a treatment for Severe Sepsis in adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Snippet

Sponsor: Eli Lilly and Company | Conditions: Severe Sepsis | Phase 4 | Status: COMPLETED